Shawn Olsson, Chief Commercial Officer of LENZ Therapeutics ($LENZ), made two open market sales of company shares over the past year, totaling about $261 thousand. His most recent sale occurred on November 17, 2025. These transactions rank 7,858th among 11,678 individual insiders by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Olsson reported no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | A | Restricted Stock Unit | 14000 | $0.00 | 14,000.0000 | 31,289,969 | 9999.99% | 0.04% |
| Jan. 2, 2026 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 84200 | $0.00 | 84,200.0000 | 31,289,969 | 9999.99% | 0.27% |
| Nov. 17, 2025 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | S | Common Stock | 4212 | $25.74 | 10,521.0000 | 31,289,969 | 28.59% | 0.01% |
| Nov. 17, 2025 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | M | Common Stock | 10000 | $2.08 | 14,733.0000 | 31,289,969 | 211.28% | 0.03% |
| Nov. 17, 2025 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | M | Stock Option (right to buy) | 10000 | $0.00 | 53,241.0000 | 31,289,969 | 15.81% | 0.03% |
| Nov. 17, 2025 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | S | Common Stock | 5788 | $26.37 | 4,733.0000 | 31,289,969 | 55.01% | 0.02% |
| April 9, 2025 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | M | Common Stock | 1400 | $2.08 | 4,733.0000 | 27,542,874 | 42.00% | 0.01% |
| April 9, 2025 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | M | Stock Option (right to buy) | 1400 | $0.00 | 63,241.0000 | 27,542,874 | 2.17% | 0.01% |
| Jan. 9, 2025 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 80100 | $0.00 | 80,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | M | Stock Option (right to buy) | 3333 | $0.00 | 64,641.0000 | 0 | 4.90% | 0.00% |
| Dec. 16, 2024 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | M | Common Stock | 3333 | $2.08 | 3,333.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 67974 | $0.00 | 67,974.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 50915 | $0.00 | 50,915.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 30466 | $0.00 | 30,466.0000 | 0 | 9999.99% | 0.00% |